Biogen | Capital De Préstamo



Loan Capital Cambio Fecha
AbbVie USD 60.34B 1.83B 2024-12
Acadia Pharmaceuticals USD 0 0 2024-12
ALKERMES USD 0 285.82M 2024-12
Amgen USD 56.55B 305M 2024-12
Bayer EUR 34.55B 2.12B 2024-12
Biogen USD 4.55B 1.4M 2024-12
BioMarin Pharmaceutical USD 595.89M 1.27M 2024-12
Bristol-Myers Squibb USD 46.16B 1.45B 2025-03
Eli Lilly USD 34.5B 5.97B 2025-03
Gilead Sciences USD 24.9B 3.46B 2024-12
Incyte USD 32.64M 899K 2025-03
Merck USD 34.46B 520M 2024-12
Moderna USD 39M 586M 2024-12
Neurocrine Biosciences USD 0 0 2024-12
Novartis USD 22.93B 2.41B 2024-12
Pfizer USD 57.4B 597M 2024-12
PTC Therapeutics USD 2.12B 179K 2024-12
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Sanofi 13.41B 1.62B 2025-03
Sanofi 11.79B 712M 2024-12
Sarepta Therapeutics USD 1.14B 1.16M 2024-12
Teva Pharmaceutical Industries USD 16B 398M 2024-12
Ultragenyx Pharmaceutical USD 0 0 2024-12
United Therapeutics USD 0 0 2025-03
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12



Biogen Capital De Préstamo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.